Table 3. Effects of CRP testing on secondary outcomes.
GP use of CRP (N = 81) n (%) |
Control (N = 99) n (%) |
Odds ratio (95% CI) |
|
---|---|---|---|
Re-consultation for baseline episode of illness | 27 (33) | 34 (34) | 0.95 (0.46 to1.99) |
Antibiotics for baseline episode of illness | 6 (7) | 8 (8) | 0.94 (0.33 to 2.63) |
Non-urgent referral to secondary care for baseline episode of illness | 3 (4) | 5 (5) | 0.93 (0.18 to 4.86) |
Consultation for new episode of RTI within 3 months | 13 (16) | 29 (29) | 0.61 (0.32 to 1.17) |
Antibiotics for new episode of RTI within 3 months | 2 (2) | 7 (7) | 0.34 (0.08 to 1.39) |
Non-urgent referral to secondary care for new episode of RTI | 3 (4) | 7 (7) | 0.54 (0.10 to 2.79) |
CI = confidence interval. RTI = respiratory tract infection.